Medsci 与 FEBS,ASBMB,Biochemical Society,中国科学 邂逅生化大会

2009-08-06 MedSci原创 MedSci原创

8月2日,第21届国际生物化学与分子生物学联盟学术大会(IUBMB)于黄浦江畔如期举行,国际生化界巨擘云集。MedSci也应邀参加会议,并同与会专家进行了深入,且富有成效的沟通和交流。

82,第21届国际生物化学与分子生物学联盟学术大会(IUBMB)于黄浦江畔如期举行,国际生化界巨擘云集。MedSci也应邀参加会议,并同与会专家进行了深入,且富有成效的沟通和交流。

特别就SCI论文发表方面,我们了解到,其实不止中国,其他很多非英语国家的作者,也在投稿SCI杂志时也存在一定的语言问题。当我们与来自于中东,东南亚,波兰的客户和杂志社进行了深入沟通后,这些用户同样反映在语言方面还是受到很大的限制;而杂志社的反馈也是,投稿来的文章,语言的逻辑与表达仍是重要的制约点。

此外,国际著名的FEBS(欧洲生物化学会联盟)、ASBMB(美国细胞生物学学会)以及Biochemical Society(生物化学学会,英国)等,我们均与之进行了愉快沟通。他们也希望通过MedSci,收到更多来自中国的高质量的稿源,同时也表示,希望中国读者能够了解和订阅他们的期刊,并邀请广大作者加入会员。

MedSci作为连接国内作者与国际期刊的桥梁和纽带,我们向众多杂志社详细介绍了国内的学术环境,特别是论文发表方面的情况,并商讨在华合作事宜。同时,他们也邀请我们MedSci向其推荐优秀稿源,并一再强调看好中国的发展前景,对来自中国的稿件非常感兴趣。比如Wiley-Blackwell出版集团旗下多本杂志都出版了China focus等专刊,集中刊登中国学者的文章。

我们MedSci将一如既往地为我们国内的学术和科研工作者服务!选择我们,脱颖而出!

 

Medsci市场经理Celine同美国portland 出版社人员合影

 

Celine同参会专家代表合影

Celine与中国科学副主任李纪元先生合影

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=37408, encodeId=300c3e40866, content=I love reading these articles because they're short but invemratifo., beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=babi, createdTime=Sun Sep 27 07:50:00 CST 2015, time=2015-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1916850, encodeId=eaf71916850e3, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sat Feb 06 18:36:00 CST 2010, time=2010-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2024181, encodeId=806e2024181cf, content=<a href='/topic/show?id=79f4219392b' target=_blank style='color:#2F92EE;'>#中国科学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21939, encryptionId=79f4219392b, topicName=中国科学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Mon May 03 13:36:00 CST 2010, time=2010-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1782967, encodeId=4a831e8296776, content=<a href='/topic/show?id=39754605d8' target=_blank style='color:#2F92EE;'>#Chemical#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4605, encryptionId=39754605d8, topicName=Chemical)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a19115, createdName=stfoxst, createdTime=Sun Apr 04 19:36:00 CST 2010, time=2010-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538, encodeId=5b85538ae, content=有交流就有收获, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb885167, createdName=medomm, createdTime=Wed Aug 19 01:01:00 CST 2009, time=2009-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605501, encodeId=185d160550133, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Aug 08 01:36:00 CST 2009, time=2009-08-08, status=1, ipAttribution=)]
    2015-09-27 babi

    I love reading these articles because they're short but invemratifo.

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=37408, encodeId=300c3e40866, content=I love reading these articles because they're short but invemratifo., beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=babi, createdTime=Sun Sep 27 07:50:00 CST 2015, time=2015-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1916850, encodeId=eaf71916850e3, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sat Feb 06 18:36:00 CST 2010, time=2010-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2024181, encodeId=806e2024181cf, content=<a href='/topic/show?id=79f4219392b' target=_blank style='color:#2F92EE;'>#中国科学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21939, encryptionId=79f4219392b, topicName=中国科学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Mon May 03 13:36:00 CST 2010, time=2010-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1782967, encodeId=4a831e8296776, content=<a href='/topic/show?id=39754605d8' target=_blank style='color:#2F92EE;'>#Chemical#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4605, encryptionId=39754605d8, topicName=Chemical)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a19115, createdName=stfoxst, createdTime=Sun Apr 04 19:36:00 CST 2010, time=2010-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538, encodeId=5b85538ae, content=有交流就有收获, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb885167, createdName=medomm, createdTime=Wed Aug 19 01:01:00 CST 2009, time=2009-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605501, encodeId=185d160550133, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Aug 08 01:36:00 CST 2009, time=2009-08-08, status=1, ipAttribution=)]
    2010-02-06 sunylz
  3. [GetPortalCommentsPageByObjectIdResponse(id=37408, encodeId=300c3e40866, content=I love reading these articles because they're short but invemratifo., beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=babi, createdTime=Sun Sep 27 07:50:00 CST 2015, time=2015-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1916850, encodeId=eaf71916850e3, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sat Feb 06 18:36:00 CST 2010, time=2010-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2024181, encodeId=806e2024181cf, content=<a href='/topic/show?id=79f4219392b' target=_blank style='color:#2F92EE;'>#中国科学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21939, encryptionId=79f4219392b, topicName=中国科学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Mon May 03 13:36:00 CST 2010, time=2010-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1782967, encodeId=4a831e8296776, content=<a href='/topic/show?id=39754605d8' target=_blank style='color:#2F92EE;'>#Chemical#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4605, encryptionId=39754605d8, topicName=Chemical)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a19115, createdName=stfoxst, createdTime=Sun Apr 04 19:36:00 CST 2010, time=2010-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538, encodeId=5b85538ae, content=有交流就有收获, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb885167, createdName=medomm, createdTime=Wed Aug 19 01:01:00 CST 2009, time=2009-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605501, encodeId=185d160550133, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Aug 08 01:36:00 CST 2009, time=2009-08-08, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=37408, encodeId=300c3e40866, content=I love reading these articles because they're short but invemratifo., beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=babi, createdTime=Sun Sep 27 07:50:00 CST 2015, time=2015-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1916850, encodeId=eaf71916850e3, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sat Feb 06 18:36:00 CST 2010, time=2010-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2024181, encodeId=806e2024181cf, content=<a href='/topic/show?id=79f4219392b' target=_blank style='color:#2F92EE;'>#中国科学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21939, encryptionId=79f4219392b, topicName=中国科学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Mon May 03 13:36:00 CST 2010, time=2010-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1782967, encodeId=4a831e8296776, content=<a href='/topic/show?id=39754605d8' target=_blank style='color:#2F92EE;'>#Chemical#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4605, encryptionId=39754605d8, topicName=Chemical)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a19115, createdName=stfoxst, createdTime=Sun Apr 04 19:36:00 CST 2010, time=2010-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538, encodeId=5b85538ae, content=有交流就有收获, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb885167, createdName=medomm, createdTime=Wed Aug 19 01:01:00 CST 2009, time=2009-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605501, encodeId=185d160550133, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Aug 08 01:36:00 CST 2009, time=2009-08-08, status=1, ipAttribution=)]
    2010-04-04 stfoxst
  5. [GetPortalCommentsPageByObjectIdResponse(id=37408, encodeId=300c3e40866, content=I love reading these articles because they're short but invemratifo., beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=babi, createdTime=Sun Sep 27 07:50:00 CST 2015, time=2015-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1916850, encodeId=eaf71916850e3, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sat Feb 06 18:36:00 CST 2010, time=2010-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2024181, encodeId=806e2024181cf, content=<a href='/topic/show?id=79f4219392b' target=_blank style='color:#2F92EE;'>#中国科学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21939, encryptionId=79f4219392b, topicName=中国科学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Mon May 03 13:36:00 CST 2010, time=2010-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1782967, encodeId=4a831e8296776, content=<a href='/topic/show?id=39754605d8' target=_blank style='color:#2F92EE;'>#Chemical#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4605, encryptionId=39754605d8, topicName=Chemical)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a19115, createdName=stfoxst, createdTime=Sun Apr 04 19:36:00 CST 2010, time=2010-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538, encodeId=5b85538ae, content=有交流就有收获, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb885167, createdName=medomm, createdTime=Wed Aug 19 01:01:00 CST 2009, time=2009-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605501, encodeId=185d160550133, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Aug 08 01:36:00 CST 2009, time=2009-08-08, status=1, ipAttribution=)]
    2009-08-19 medomm

    有交流就有收获

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=37408, encodeId=300c3e40866, content=I love reading these articles because they're short but invemratifo., beContent=null, objectType=article, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=babi, createdTime=Sun Sep 27 07:50:00 CST 2015, time=2015-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1916850, encodeId=eaf71916850e3, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sat Feb 06 18:36:00 CST 2010, time=2010-02-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2024181, encodeId=806e2024181cf, content=<a href='/topic/show?id=79f4219392b' target=_blank style='color:#2F92EE;'>#中国科学#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=21939, encryptionId=79f4219392b, topicName=中国科学)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=66ec123, createdName=guihongzh, createdTime=Mon May 03 13:36:00 CST 2010, time=2010-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1782967, encodeId=4a831e8296776, content=<a href='/topic/show?id=39754605d8' target=_blank style='color:#2F92EE;'>#Chemical#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4605, encryptionId=39754605d8, topicName=Chemical)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1a19115, createdName=stfoxst, createdTime=Sun Apr 04 19:36:00 CST 2010, time=2010-04-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538, encodeId=5b85538ae, content=有交流就有收获, beContent=null, objectType=article, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb885167, createdName=medomm, createdTime=Wed Aug 19 01:01:00 CST 2009, time=2009-08-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1605501, encodeId=185d160550133, content=<a href='/topic/show?id=eb6b1145939' target=_blank style='color:#2F92EE;'>#Med#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=11459, encryptionId=eb6b1145939, topicName=Med)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=552a19396740, createdName=ms3994565386320060, createdTime=Sat Aug 08 01:36:00 CST 2009, time=2009-08-08, status=1, ipAttribution=)]

相关资讯

五一放假通知

   按照国家法定假日规定,五一劳动节放假一天。加上周末,我公司劳动节放假时间为5月1日—3日。  假日期间,公司仍然正常接收稿件,但是5月4号以后才会进行处理,祝大家度过一个愉快祥和的假期。                  &

网站全面升级,解决近期网站出现相关问题

由于网站访问量快速上升(最近5个月,访问量上升了3倍),原有的系统已不能承载用户的访问,象SCI影响因子查询,新闻全文搜索,会员登录,上传文章等功能都无法正常使用。 因此,昨日对网站进行全面升级改造,对网站的负荷提升10倍以上。但是升级过程中,仍然出现一些程序上的bug,昨天下午大量会员来信反映,为什么无法登录了?我们工作人员紧急处理,直至昨夜深夜,程序的bug被清扫一遍。 如果您在使用网站过

SCI论文翻译的质量要求 不是普通的翻译

有关SCI论文翻译,一般认为就是普通的中译英而已。包括我们medsci.cn经常接收到大量“英文”稿件,但是非常明显,这是作者自译,或作者花钱请翻译公司翻译的,全文接近“看不懂!”,更不说老外了。我们中国人的英语,一般中国人还是能懂的,但不代表外籍编辑或杂志编辑能懂!这实际上表明,SCI论文翻译,是所有翻译领域,要求最高的。 所以许多翻译公司,甚至是生物医学业内的翻译公司,他们都无法承受SCI论

MedSci参加干细胞之春系列活动--干细胞技术与应用讲座

    生物谷(Bioon.com)2009年5月20日,中国上海:"干细胞之春系列活动--干细胞技术与应用讲座"在上海好望角大饭店隆重召开,本期讲座为期两天,近300位从事干细胞及再生医学研究的科研人员、医生及教师等齐聚一堂,共谱我国干细胞产业未来宏图。     此次讲座邀请到16位国内干细胞研究及应用领域的顶级专家及知名企业相关

干细胞研究趋势分析与课题申报(下载)

下载:干细胞研究趋势分析与课题申报(PDF文件,950K) MedSci应邀参加此次盛会,并发表主题演讲“干细胞研究趋势分析与课题申报”,这里提供幻灯片下载。

MedSci参加第6届中国蛋白质组学大会

2009年7月29日至31日在江苏泰州举办的第6届中国蛋白质组学大会,本次大会由中国生物化学与分子生物学会蛋白质组学专业委员会(CNHUPO)主办,北京蛋白质组研究中心和复旦大学共同承办。MedSci工作人员参加了此次盛会。 大会开幕式由中国生物化学与分子生物学会蛋白质组学专业委员会执行主席杨晓明主持,中国生物化学与分子生物学会蛋白质组学专业委